News

Advances in glycochemistry, peptide labeling and nucleoside synthesis are lifting global demand for N-Iodosuccinimide (NIS, CAS 516-12-1), a mild electrophilic iodinating reagent widely used to activate glycosyl donors for stereoselective glycosylation reactions

Recent academic publications in carbohydrate chemistry highlight NIS as a practical, low-byproduct promoter for complex oligosaccharide assembly, vaccine glycan construction and biopharma intermediate development. Compared with elemental iodine, NIS delivers better reaction controllability under mild conditions and simplifies post-reaction purification, which is critical for CRO and biotech R&D teams working on high-value biological targetsScience.

Because NIS is mostly consumed in small-batch, high-value research workflows, reliable high-purity supply (99%) is a major priority for global biotech and synthetic chemistry labs. Product stability, batch consistency and proper hazardous-material packaging are key evaluation criteria for international buyers.

We supply 99% N-Iodosuccinimide for lab trial and commercial synthesis. Technical data, safety sheets and sample arrangements are available for global researchers and chemical enterprises.